Mallinckrodt Pays $35M To Settle Federal Investigations Of Controlled Substances
WASHINGTON, D.C. — Opioid drug maker Mallinckrodt LLC has agreed to pay $35 million to settle three federal investigations into the company’s alleged violations of the Controlled Substances Act, the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article